Viridos
Viridos is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineers are shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com.
Work at Viridos in HR or recruiting? Claim this page
Headcount trend
Viridos went from 48 employees in Oct 2024 to 34 in Sep 2026.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Mar 2023 | Series A | $25M | 2 | |
| Mar 2023 | Funding | $5M | 2 | |
| Sep 2019 | Series A | $25M | 3 | |
| Sep 2015 | Funding | $50M | 1 | |
| Apr 2014 | Funding | $50M | 1 |
Org structure
Headcount by department
H-1B sponsorship
Peer reviews
Worked with someone at Viridos?
Anonymous peer reviews on OffTheRecord
Similar companies
Viridos FAQ
How many employees does Viridos have?
Viridos has about 34 employees, unchanged over the 3 months to Sep 2026.
Does Viridos sponsor H1B visas?
Yes. Viridos filed 1 H1B (LCA) application in FY2024, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.
What is Viridos's revenue per employee?
Viridos makes about $1.32M in revenue per employee, based on $45M annual revenue and 34 employees.
How much funding has Viridos raised?
Viridos has raised $155M in total funding; its latest round was Series A in Mar 2023.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.